Anti-Cripto1 antibody [EPNCIR106A] (ab108391)


  • Product nameAnti-Cripto1 antibody [EPNCIR106A]
    See all Cripto1 primary antibodies
  • Description
    Rabbit monoclonal [EPNCIR106A] to Cripto1
  • Tested applicationsSuitable for: WB, IP, ICC, Flow Cytmore details
    Unsuitable for: IHC-P
  • Species reactivity
    Reacts with: Human
  • Immunogen

    A synthetic peptide corresponding to residues in Human Cripto 1.

  • Positive control
    • NCCIT cell lysate
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of David Solomon.

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

    Alternative versions available:

    Anti-Cripto1 antibody (HRP) [EPNCIR106A] (ab203468)

    Produced using Abcam's RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5, 675, 063 and/or 7, 429, 487.

    We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.



Our Abpromise guarantee covers the use of ab108391 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Detects a band of approximately 21 kDa (predicted molecular weight: 21 kDa).
IP 1/10 - 1/100.
ICC 1/100 - 1/250.
Flow Cyt Use at an assay dependent concentration.
  • Application notesIs unsuitable for IHC-P.
  • Target

    • FunctionCould play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.
    • Tissue specificityPreferentially expressed in gastric and colorectal carcinomas than in their normal counterparts.
    • Sequence similaritiesContains 1 EGF-like domain.
    • Cellular localizationCell membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • CR antibody
      • CRGF antibody
      • Cripto 1 antibody
      • Cripto 1 growth factor antibody
      • cripto antibody
      • Cripto-1 growth factor antibody
      • Cripto1 growth factor antibody
      • Epidermal growth factor like cripto protein CR1 antibody
      • Epidermal growth factor-like cripto protein CR1 antibody
      • TDGF 1 antibody
      • TDGF1 antibody
      • TDGF1_HUMAN antibody
      • Teratocarcinoma derived growth factor 1 antibody
      • Teratocarcinoma-derived growth factor 1 antibody
      see all

    Anti-Cripto1 antibody [EPNCIR106A] images

    • Flow Cytometry analysis of NCCIT(human pluripotent embryonal carcinoma) cells labeling Cripto1 with purified ab108391 
      at 1/2200 dilution (1ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488)(1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

    • Anti-Cripto1 antibody [EPNCIR106A] (ab108391) at 1/1000 dilution + NCCIT cell lysate at 10 µg

      Predicted band size : 21 kDa
      Observed band size : 21 kDa

    References for Anti-Cripto1 antibody [EPNCIR106A] (ab108391)

    ab108391 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab108391.
    Please use the links above to contact us or submit feedback about this product.